Literature DB >> 21332313

Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion.

Maria Satra1, Maria Samara, Greta Wozniak, Chara Tzavara, Angelos Kontos, Varvara Valotassiou, Nikolaos K Vamvakopoulos, Ioannis Tsougos, Vassiliki Aleporou-Marinou, George P Patrinos, Panagoula Kollia, Panagiotis Georgoulias.   

Abstract

AIMS: Coronary artery disease (CAD) is a significant cause of morbidity and mortality in modern societies. The association between genetic markers and CAD is still poorly understood. In this study, we evaluated the effect of five genetic variants: Factor V Leiden (FV:c.1691G>A) (rs6025), Factor II prothrombin (FII:c.20210G>A; rs1799963), plasminogen activator inhibitor 1 (PAI-1) -675(4G/5G; SERPINE1:g.4329_4330insG; rs34857375), β-fibrinogen -455G>A (FGB:c.4577G>A; rs1800790) and Factor XIII (F13A1:c.103G>T; rs5985) on myocardial perfusion. MATERIALS &
METHODS: We examined 523 patients using exercise-rest myocardial perfusion single photon emission computed tomography, where the summed stress score (SSS), summed rest score and summed difference score (SDS) indexes, were calculated. In order to examine the independent prognostic ability of genotype on SSS and SDS, multiple linear regression models were used.
RESULTS: It was found that Factor V Leiden, Factor XIII, β-fibrinogen and PAI-1 genotypes were independent prognostic predictors of SSS and SDS with Factor XIII exhibiting the strongest association. Moreover, Factor II prothrombin proved an independent prognostic predictor of SSS.
CONCLUSION: Our study provides the first evidence of an association between these polymorphisms and myocardial perfusion, suggesting that the process of coronary artery disease and also patients' prognosis, may be modified by the FV:c.1691G>A, FII:c.20210G>A, PAI-1 -675 (4G/5G), β-fibrinogen FGB:c.4577G>A and F13A1:c.103G>T genotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21332313     DOI: 10.2217/pgs.10.180

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  4 in total

1.  Are centenarians genetically predisposed to lower disease risk?

Authors:  Jonatan R Ruiz; Carmen Fiuza-Luces; Amaya Buxens; Amalia Cano-Nieto; Félix Gómez-Gallego; Catalina Santiago; Gabriel Rodríguez-Romo; Nuria Garatachea; José I Lao; María Morán; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2011-09-06

2.  Impact of renin-angiotensin-aldosterone system polymorphisms on myocardial perfusion: Correlations with myocardial single photon emission computed tomography-derived parameters.

Authors:  George Angelidis; Maria Samara; Maria Papathanassiou; Maria Satra; Varvara Valotassiou; Ioannis Tsougos; Dimitrios Psimadas; Chara Tzavara; Sotiria Alexiou; John Koutsikos; Nikolaos Demakopoulos; Gregory Giamouzis; Filippos Triposkiadis; John Skoularigis; Panagoula Kollia; Panagiotis Georgoulias
Journal:  J Nucl Cardiol       Date:  2018-01-17       Impact factor: 5.952

3.  Endothelial Nitric Oxide Synthase T-786C Mutation, Prothrombin Gene Mutation (G-20210-A) and Protein S Deficiency Could Lead to Myocardial Infarction in a Very Young Male Adult.

Authors:  Milka Klincheva; Elena Ambarkova Vilarova; Tanja Angjusheva; Ivan Milev; Enver Idoski; Zan Mitrev
Journal:  Open Access Maced J Med Sci       Date:  2016-01-29

4.  The Correlation Between FGB Promoter Polymorphism and Clotting Function in Patients With Idiopathic Lower Extremity Deep Venous Thrombosis.

Authors:  Shengbin Han; Bin Yang; Yaoyu Feng; Lingfeng Zhao; Qun Feng; Hongxi Guan; Donghui Song; Fang Yin; Li Zhuang
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.